Achieving Optimal Medical Therapy: Insights From the ORBITA Trial

BACKGROUND: In stable coronary artery disease, medications are used for 2 purposes: cardiovascular risk reduction and symptom improvement. In clinical trials and clinical practice, medication use is often not optimal. The ORBITA (Objective Randomised Blinded Investigation With Optimal Medical Therap...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:J Am Heart Assoc
Hlavní autoři: Foley, Michael, Rajkumar, Christopher A., Shun‐Shin, Matthew, Ganesananthan, Sashiananthan, Seligman, Henry, Howard, James, Nowbar, Alexandra N., Keeble, Thomas R., Davies, John R., Tang, Kare H., Gerber, Robert, O’Kane, Peter, Sharp, Andrew S. P., Petraco, Ricardo, Malik, Iqbal S., Nijjer, Sukhjinder, Sen, Sayan, Francis, Darrel P., Al‐Lamee, Rasha
Médium: Artigo
Jazyk:Inglês
Vydáno: John Wiley and Sons Inc. 2021
Témata:
Original Research
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7955412/
https://ncbi.nlm.nih.gov/pubmed/33496201
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/JAHA.120.017381
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky